tirzepatide for osa (Zepbound) – A New Treatment Obstructive Sleep Apnea and Obesity — BetterNight Zepbound Approved to Treat Obstructive

Weight reduction is typically gradual, with the greatest changes seen in the first six to twelve months of treatment

Walking, yoga, or moderate cardio during a morning fast is safe for most GLP-1 users and may enhance fat oxidation during the fasting period

Importantly, tirzepatide is FDA approved and commercially available right now

Ozempic and other GLP-1 drugs have been linked to blurry vision, diabetic retinopathy, nAMD, and NAION

It also inhibits melanin production, lightening skin

For individuals seeking to lose weight safely, the most effective strategy remains a personalised, evidence-based programme that combines licensed medication (where appropriate), nutritional guidance, physical activity, behavioural support and regular clinical monitoring